Cheryl Cohen - Aug 20, 2021 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Steven Yang, as Attorney-in-Fact
Stock symbol
IBRX
Transactions as of
Aug 20, 2021
Transactions value $
-$249,603
Form type
4
Date filed
8/24/2021, 06:07 PM
Previous filing
Aug 19, 2021
Next filing
Jun 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBRX Common Stock Sale -$99.8K -9.98K -4.43% $10.00 215K Aug 20, 2021 Direct F1, F2
transaction IBRX Common Stock Sale -$150K -14.8K -6.87% $10.12 201K Aug 23, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021.
F2 Represents the weighted average share price of an aggregate total of 9,976 shares sold in the price range of $10.00 to $10.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 14,801 shares sold in the price range of $10.02 to $10.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.